Awareness, treatment, and control of arterial hypertension: Pró-Saúde Study, Brazil;Reconhecimento, tratamento e controle da hipertensão arterial: Estudo Pró-Saúde, Brasil

Revista Panamericana de Salud Publica/Pan American Journal of Public Health

Volumn 27, Issue 2, 2010, Pages 103-109

  Nogueira, Danielle ^a,b   Faerstein, Eduardo ^a   Coeli, Claudia Medina ^c   Chor, Dora ^d   De Souza Lopes, Claudia ^a   Werneck, Guilherme Loureiro ^a,c  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^d INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Brazil; Control; Diagnosis; Epidemiology; Hypertension; Prevalence; Therapeutics

Indexed keywords

DISEASE CONTROL; DISEASE PREVALENCE; DISEASE TREATMENT; DRUG PRESCRIBING; EPIDEMIOLOGY; HEALTH POLICY; HYPERTENSION; POPULATION STRUCTURE;

ADULT; ARTICLE; ATTITUDE TO HEALTH; BRAZIL; FEMALE; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDY;

ADULT; BRAZIL; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES;

BRAZIL; RIO DE JANEIRO [BRAZIL];

EID: 77950177791     PISSN: 10204989     EISSN: 16805348     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Hajjar I, Kotchen JM, Kotchen TA. Hypertension: trends in prevalence, incidence, and control. Annu Rev Public Health. 2006;27:465-490
2. Brasil, Ministério da Saúde. Plano de reorganizaç ão da atenção à hipertensão arterial e ao diabetes mellitus. Manual de hipertensão arterial e diabetes mellitus. Brasília: Ministério da Saúde; 2002.
3. Kannel WB. Blood pressure as a cardiovascular risk factor: prevention and treatment. JAMA. 1996;275(20):1571-1576
4. Joffres MR, Hamet P, Rabkin SW, Gelskey D, Hogan K, Fodor G. Prevalence, control and awareness of high blood pressure among Canadians adults. Canadian Heart Health Surveys Research Group. CMAJ. 1992;146(11):1997-2005.
5. Ambrosioni E, Leonetti G, Pessina AC, Rappelli A, Trimarco B, Zanchetti A. Patterns of hypertension management in Italy: results of a pharmacoepidemiological survey on antihypertensive therapy. Scientific Committee of the Italian Pharmacoepidemiological Survey on Antihypertensive Therapy. J Hypertens. 2000;18(11):1691-1699
6. Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, et al. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet. 1990;335 (8693):827-838
7. Wilber JA, Barrow JG. Hypertension - a community problem. Am J Med. 1972;52(5):653-663
8. Kearney PM, Whelton M, Reynolds K, Whelton PK, He J. Worldwide prevalence of hypertension: a systematic review. J Hypertens. 2004;22(1):11-19
9. Freitas OC, Carvalho FR, Neves JM, Veludo PK, Parreira RS, Gonçalves RM, et al. Prevalência da hipertensão arterial sistêmica na população urbana de Catanduva, SP. Arq Bras Cardiol. 2001;77(1):9-21.
10. Gus I, Harzheim E, Zaslavsky C, Medina C, Gus M. Prevalência, reconhecimento e controle da hipertensão arterial sistêmica no estado do Rio Grande do Sul. Arq Bras Cardiol. 2004;83(5):429-433
11. Pereira MR, Coutinho MSSA, Freitas PF, D'Orsi E, Bernardi A, Hass R. Prevalência, conhecimento, tratamento e controle de hipertensão arterial sistêmica na população adulta urbana de Tubarão, Santa Catarina, Brasil, em 2003. Cad Saude Publica. 2007;23 (10):2363-2374
12. Piccini RX, Victora CG. Hipertensão arterial sistêmica em área urbana no sul do Brasil: prevalência e fatores de risco. Rev Saude Publica. 1994;28(4):261-7.
13. Souza LJ, Chalita FEB, Reis AFF, Teixeira CL, Bastos DA, Souto Filho JTD, et al. Epidemiologia da hipertensão arterial sistêmica em Campos dos Goytacazes/ RJ. Em: Couto AA, Kaiser SE, org. Manual de hipertensão arterial da Sociedade de Hipertensão do Estado do Rio de Janeiro (SOHERJ) Rio de Janeiro: Lemos; 2003. Pp. 26-35.
14. Souza ARA, Costa A, Nakamura D, Mocheti LM, Stevanato Filho PR, Ovando LA. Um estudo sobre hipertensão arterial sistêmica na cidade de Campo Grande, MS. Arq Bras Cardiol. 2007;88(4):441-446
15. Faerstein E, Chor D, Griep RH, Alves MGM, Werneck GL, Lopes CS. Aferição da pressão arterial: experiência de treinamento de pessoal e controle de qualidade no Estudo Pró- Saúde. Cad Saude Publica. 2006;22(9): 1997-2002.
16. a ed. Londres: BMJ Books; 2001.
17. World Health Organization-International society of hypertension guidelines for the management of hypertension. Guidelines Subcommittee. J Hypertens. 1999; 17(2):151-183
18. DEF. Dicionário de especialidade farmacêuticas. Rio de Janeiro: EPUB; 2001/2002.
19. Passos VMA, Assis TD, Barreto SM. Hipertensão arterial no Brasil: estimativa de prevalência a partir de estudos de base populacional. Epidemiol Serv Saude. 2006;15(1): 35-45.
20. Altun B, Arici M, Nergizoglu G, Derici U, Karatan O, Turgan C, et al. Prevalence, awareness, treatment and control of hypertension in Turkey (the Paten T study) in 2003. J Hypertens. 2005;23(10):1817-1823
21. Fasce E, Campos I, Ibáñez P, Flores M, Zárate H, Román O, et al. Trends in prevalence, awareness, treatment and control of hypertension in urban communities in Chile. J Hypertens. 2007;25(9):1807-1811
22. Mancia G, Parati G, Borghi C, Ghironzi G, Andriani E, Marinelli L, et al. Hypertension prevalence, awareness, control and association with metabolic abnormalities in the San Marino population: the SMOOTH study. J Hypertens. 2006;24(5):837-843
23. Toscano CM. As campanhas nacionais para detecção das doenças crônicas não-transmissíveis: diabetes e hipertensão arterial. Cien Saude Colet. 2004;9(4):885-895
24. Banegas JR, Rodriguez-Artalejo F, de la Cruz Troca JJ, Guallar-Castillón P, Del Rey Calero J. Blood pressure in Spain: distribution, awareness, control, and benefits of a reduction in average pressure. Hypertension. 1998;32(6):998-1002.
25. Li W, Jiang X, Ma H, Yu TS, Ma L, Puente JG, et al. Awareness, treatment and control of hypertension in patients attending hospital clinics in China. J Hypertens. 2003;21(6):1191-1197
26. Psaltopoulou T, Orfanos P, Naska A, Lenas D, Trichopoulos D, Trichopoulou A. Prevalence, awareness, treatment and control of hypertension in a general population sample of 26,913 adults in the Greek EPIC study. Int J Epidemiol. 2004;33(6):1345-1352
27. Van Rossum CT, van De Mheen H, Witteman JC, Hofman A, Mackenbach JP, Grobbee DE. Prevalence, treatment, and control of hypertension by sociodemographic factors among the Dutch elderly. Hypertension. 2000;35(3): 814-821
28. Howard G, Prineas R, Moy C, Cushman M, Kellum M, Temple E, et al. Racial and geographic differences in awareness, treatment, and control of hypertension: the Reasons for Geographic and Racial Differences in Stroke study. Stroke. 2006;37(5):1171-1178
29. de Gaudemaris R, Lang T, Chatellier G, Larabi L, Lauwers-Cances V, Maitre A, et al. Socioeconomic inequalities in hypertension prevalence and care: the IHPAF Study. Hypertension. 2002;39(6):1119-1125
30. Lim TO, Morad Z, Hypertension Study Group. Prevalence, awareness, treatment and control of hypertension in the Malaysian adult population: results from the national health and morbidity survey 1996. Singapore Med J. 2004;45(1):20-27
31. Amoah AG. Hypertension in Ghana: a crosssectional community prevalence study in greater Accra. Ethn Dis. 2003;13(3):310-315
32. Marques-Vidal P, Tuomilehto J. Hypertension awareness, treatment and control in the community: is the 'rule of halves' still valid? J Hum Hypertens. 1997;11(4):213-220
33. Fuentes R, Ilmaniemi N, Laurikainen E, Tuomilehto J, Nissinen A. Hypertension in developing economies: a review of population- based studies carried out from 1980 to 1998. J Hypertens. 2000;18(5):521-529
34. Whelton PK, He J, Muntner P. Prevalence, awareness, treatment and control of hypertension in North America, North Africa and Asia. J Hum Hypertens. 2004;18(8):545-551
35. Perez-Fernandez R, Mariño AF, Cadarso- Suarez C, Botana MA, Tome MA, Solache I, et al. Prevalence, awareness, treatment and control of hypertension in Galicia (Spain) and association with related diseases. J Hum Hypertens. 2007;21(5):366-373
36. Sehestedt T, Ibsen H, Jorgensen T. Awareness, treatment and control of hypertension in Denmark. The Inter99 study. Blood Press. 2007;16(5):312-319
37. Shea S. Hypertension control, 1994. Am J Public Health. 1994;84(11):1725-1727
38. World Health Organization. Adherence to long-term therapies: evidence for action. Genebra: WHO; 2003.
39. Dowell J, Jones A, Snadden D. Exploring medication use to seek concordance with "non-adherent" patients: a qualitative study. Br J Gen Pract. 2002;52(474):24-32.
40. Scheltens T, Bots ML, Numans ME, Grobbee DE, Hoes AW. Awareness, treatment and control of hypertension: the 'rule of halves' in an era of risk-based treatment of hypertension. J Hum Hypertens. 2007;21(2):99-106.
41. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42(6):1206-1252
42. Ruzicka M, Leenen FH. Moving beyond guidelines: are report cards the answer to high rates of uncontrolled hypertension? Curr Hypertens Rep. 2006;8(4):324-329
43. Berlowitz DR, Ash AS, Hickey EC, Friedman RH, Glickman M, Kader B, et al. Inadequate management of blood pressure in a hypertensive population. N Engl J Med. 1998;339(27): 1957-1963
44. Mion Jr. D, Pierin AMG, Guimarães A. Tratamento da hipertensão arterial - respostas de médicos brasileiros a um inquérito. Rev Assoc Med Bras. 2001;47(3):249-254
45. Stockwel DH, Madhavan S, Cohen H, Gibson G, Alderman MH. The determinants of hypertension awareness, treatment, and control in an insured population. Am J Public Health. 1994;84(11):1768-1774
46. Primatesta P, Poulterb NR. Improvement in hypertension management in England: results from the Health Survey for England 2003. J Hypertens. 2006;24(6):1187-1192
47. Perez-Fernandez R, Mariño AF, Cadarso- Suarez C, Botana MA, Tome MA, Solache I, et al. Prevalence, awareness, treatment and control of hypertension in Galicia (Spain) and association with related diseases. J Hum Hypertens. 2007;21(5):366-373
48. Zachariah MG, Thankappan KR, Alex SC, Sarma PS, Vasan RS. Prevalence, correlates, awareness, treatment, and control of hypertension in a middle-aged urban population in Kerala. Indian Heart J. 2003;55(3):245-251
49. Burnier M. Medication adherence and persistence as the cornerstone of effective antihypertensive therapy. Am J Hypertens. 2006; 19(11):1190-1196
50. Marques-Vidal P, Arveiler D, Amouyel P, Bingham A, Ferrières J. Sex differences in awareness and control of hypertension in France. J Hypertens. 1997;15(11):1205-1210
51. Chen R, Tunstall-Pedoe H, Morrison C, Connaghan J, A'Brook R. Trends and social factors in blood pressure control in Scottish MONICA surveys 1986-1995: the rule of halves revisited. J Hum Hypertens. 2003;17(11):751-759
52. Macedo ME, Lima MJ, Silva AO, Alcantara P, Ramalhinho V, Carmona J. Prevalence, awareness, treatment and control of hypertension in Portugal: the PAP study. J Hypertens. 2005;23(9):1661-1666
53. Schelleman H, Klungel OH, Kromhout D, Boer A, Stricker BH, Verschuren WM. Prevalence and determinants of undertreatment of hypertension in the Netherlands. J Hum Hypertens. 2004;18(5):317-324
54. Birkett NJ. The effect of alternative criteria for hypertension on estimates of prevalence and control. J Hypertens. 1997;15(3):237-244
55. US Department of Health and Human Services. Healthy people 2010. 2a ed. Washington: US Government Printing; 2000.